Gold prices tick higher on fresh US tariff threats, Fed rate cut hopes
Investing.com - Adapthealth (NASDAQ: AHCO) reported second quarter EPS of $0.10, $0.06 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $800.4M versus the consensus estimate of $804.97M.
Guidance
Adapthealth sees FY 2025 revenue of $3.18B-$3.26B versus the analyst consensus of $3.24B.
Adapthealth’s stock price closed at $9.11. It is up 8.78% in the last 3 months and up 5.20% in the last 12 months.
Adapthealth saw 0 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Adapthealth’s stock price’s past reactions to earnings here.
According to InvestingPro, Adapthealth’s Financial Health score is "great performance".
Check out Adapthealth’s recent earnings performance, and Adapthealth’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar